MorphoSys AG
XMUN:MOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MorphoSys AG
XMUN:MOR
|
DE |
|
O
|
Organon & Co
F:7XP
|
US |
|
K
|
Kforce Inc
XMUN:ROF
|
US |
|
Outlook Therapeutics Inc
F:41O
|
US |
|
S
|
Salesforce Inc
F:FOO
|
US |
|
I
|
IWG Plc
F:IWG
|
CH |
|
R
|
Revance Therapeutics Inc
F:RTI
|
US |
|
I
|
Indo Tambangraya Megah Tbk PT
XMUN:3IB
|
ID |
|
Z
|
Zions Bancorporation NA
F:ZB1
|
US |
|
T
|
Telenor ASA
DUS:TEQ
|
NO |
|
Global Industrial Co
F:GML0
|
US |
|
Electro-Sensors Inc
NASDAQ:ELSE
|
US |
|
V
|
Vesuvius PLC
F:V4S
|
UK |
|
Z
|
Ziff Davis Inc
XMUN:JXC1
|
US |
|
Akari Therapeutics PLC
F:CLA
|
US |
|
S
|
Saul Centers Inc
F:SA4
|
US |
Bankruptcy Probability
MorphoSys AG's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
MorphoSys AG Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| DE |
|
MorphoSys AG
XETRA:MOR
|
2.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
398.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
186.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
MorphoSys AG's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, MorphoSys AG has total debt of 255.2m EUR. This includes both short-term (0 EUR) and long-term (255.2m EUR) debt.
You can find a full breakdown on its Balance Sheet.
